Elevai Labs Inc (ELAB) Quote

Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare

This stock just can't stay up....someone give this pos some Viagra!

https://stocktwits.com/3227blake/message/562545429

$ELAB bottom chart 1.8M float no dilution and 6.6 months of cash with 22.07% 13D out today, only 20k short shares left pic.twitter.com/EFsfxgkXqv— STOCKS Gambino (@StocksGambino) February 21, 2024

ELAB: Had skin care Patent, 1-wk. ago; maybe now an outright cure for all CANCERS??? (Joking)

Goodmorning

and then randomly 4am .70-1.65 no news, just some more games

if it breaks 1.65 it could go

otherwise 1 & done pos pump 2.0

ELAB $1.64 just a quick premarket flip they can do all the dilution they want after 7am..lol

NO THX https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173636262

EVEN THOUGH i MADE A SMALL TRADE AND SOLD 1.49

ELAB IS STILL A POS IMO

Almost hit 1.30 zones 1.39- 1.60 further up

Dilution? Total mess.

Dilution? Total mess.

$ELAB MORE NEWS Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

https://newsfilter.io/articles/elevai-labs-inc-reports-strong-preliminary-unaudited-financial-performance-for-fiscal-year-2023-high-6ea3644ed452e4ef1c28f33c0f9f63c8

Yes, very strange
Morning news Today the/ Shorts piled in:((

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs to commercialize use of proprietary technology designed to produce high-quality, cGMP grade mesenchymal stromal cells at lower-cost

NEWPORT BEACH, Calif., Jan. 16, 2024 -- InvestorsHub NewsWire -- Elevai Labs, Inc. (Nasdaq: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc., [Nasdaq: INMB]. The licensing agreement grants Elevai a license to use INmune Bio's proprietary "EMx" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice ("cGMP") grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.

Elevai believes incorporating the "EMx" technology into its operations is a step towards the company's goal of achieving vertical manufacturing integration, while also expanding long-term production capabilities and lowering overall costs. Ultimately, Elevai believes controlling its processes through its product pipeline with what it believes to be efficient technologies like "EMx" will allow greater stem cell consistency, purity, and propel Elevai's branded cosmetic products further to maintain the company's position as an industry innovator in the medical aesthetics skincare marke

SEC gives no shits

this is exactly why we 100% need Crypto, every share will be tracked every step of the way long or short

now its all a mystery, with offshore BS

cryptonize the stock market to STOP this naked shorting BS

a long time ago one senator wanted to add a serial # like a vin# to every share so companies, and shareholders could account for every share

well crypto enables exactly that, and is fully transparent on the blockchain

#THINKABOUTIT

Classic chat pump & dump naked short
To 1.00;((

definitely not a good way to start a business.

LOOKS LIKE NEWS PUMP TO DUMP SHARES IMO

https://elevaiskincare.com/
FLUFFY PUFFY SKIN ..NEWS

OVER EXTENDED POP

GAP & TRAP

BUT -11.11% IS DOWN RIGHT DISGUSTING AFTER BEING UP UP OVER 100% 4.38 HIGH

$ELAB

this is looking very interesting. The rise is due to the acquisition. Why the fall?

Hello world:)

Recent ipo